TCPA protein expression and associated clinical data analysis revealed SETD2 high expression is associated with poor prognosis in PCa samples OS (HR: 13.6) and DFS (HR: 7.96) (Figure 3A,B). This evidence concerns the gene SETD2 and posterior cortical atrophy.